Prof. Jean-Pierre Kraehenbuhl - Oncology Online: Development of a web-based oncology teaching program
Prof. Jean-Pierre Kraehenbuhl
Head of the E-learning program Oncology Online
Health Sciences eTraining Foundation (HSeT)
155, chemin des Boveresses
CH-1066 Epalinges sur Lausanne
Switzerland
Tel: +41/21 692 58 56
CH-1066 Epalinges sur Lausanne
Switzerland
Tel: +41/21 692 58 56
Oncology Online
A web-based teaching program for molecular and clinical oncology called Oncology online will be developed within the next four years of the NCCR program. Oncology online (Fig. 1) will benefit from the expertise and know-how accumulated within “Immunology on Line” (http://www.iol.ch), a project funded by the Swiss Virtual Campus program, and OCTAVE (http://octave.bio-med.ch/), a collaborative effort between the HSeT Foundation, the Office of AIDS research and HVTN (HIV vaccine trial network) from the National Institutes of Health and the World Health Organization. A team of e-Learning manager, web-masters, developers has been recruited. New pedagogical approaches and a platform with common and individual services have been developed and are available for Oncology Online.
|
|
|
Figure 1 : Homepage of Oncology Online.
Oncology online is a team effort among partners of the University Hospital (CHUV), ISREC, NCCR and EPFL (Table 1).
|
|
|
|
Figure 2 : Partners on Oncology online.
Oncology online requires the collaboration between an e-learning core-team and the scientists and clinicians that provide the content- The number of contributors will increase as the project progresses |
Oncology online will allow medical and biology students from Switzerland to have autonomous access to basic information on molecular oncology including tumorigenesis, oncogenic signaling, tumor microenvironment, tumor prevention and diagnosis, tumor therapy. This web-based course provides the students and the trainees with learning tools that will be available during their entire training process including teaching modules, containing hypertext-based lectures laced with multimedia content (images, animations and videos); exercises, presented under the form of questions and simulations, a virtual lab and a microscope.
Master of Advanced Studies in Investigative Oncology
The fight against cancer depends on the integration of basic and clinical research. The Master of Advanced Studies in Investigative Oncology (MASIO) uses innovative approaches to effectively promote this integration in the rapidly changing field of Oncology.
MASIO is a 3-year program providing training in Clinical research with an emphasis on molecular oncology, Clinical & translational research, Clinical trial design.
MASIO encompasses 60 credits (conform to the European Credit Transfer System). The Master diploma is delivered by the University of Lausanne. The program is endorsed by Swiss and European Medical Faculties and by major Oncology Centers.
MASIO targets physicians specializing in a domain related to oncology and medically oriented scientists that pursue clinical research .
MASIO is a 3-year program providing training in Clinical research with an emphasis on molecular oncology, Clinical & translational research, Clinical trial design.
MASIO encompasses 60 credits (conform to the European Credit Transfer System). The Master diploma is delivered by the University of Lausanne. The program is endorsed by Swiss and European Medical Faculties and by major Oncology Centers.
MASIO targets physicians specializing in a domain related to oncology and medically oriented scientists that pursue clinical research .
|
|
|
Figure 2. During the two first years, the trainees spend one full day a week acquiring knowledge and skills through distance learning and four weeks in face to face workshops. |
The first year is devoted to:
- Molecular and clinical oncology through 16 cases related to the main cancer types. Each cancer is associated with one concept in molecular oncology and one clinical paradigm. At the end of each cycle of 4 cases, the students meet in a face to face workshop and take an exam
- The selection of the host laboratory in which the trainees will perform their research or clinical project.
The second year consists of:
- A module on the design, conduct, and management of clinical trials.
- A module on the conduct of translational research projects in oncology.
- Practicals organized to familiarize the trainees with the methodology they will use in the translational research module.
During the third year, the trainees perform a master project for a period of at least 6 months.


